• Ownership

James Healy - Insider Trading & Ownership

Entity
Individual
Location
3000 Sand Hill Road, 4 250, Menlo Park, CA
Summary
The estimated net worth of James Healy is at least $376M dollars as of February 4, 2025. James Healy is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $282M. James Healy is the Director of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $41.5M. James Healy is the Director of Y-mAbs Therapeutics, Inc. and owns shares of Y-mAbs Therapeutics, Inc. (YMAB) stock worth about $26.7M. James Healy is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $19.9M. James Healy is the Director of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $6.19M. James Healy is the Director of Coherus BioSciences, Inc. and owns shares of Coherus BioSciences, Inc. (CHRS) stock worth about $171K.
All Insider Reports
All Insider Reports

Ownership of James Healy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTRA Natera, Inc. Director $282M Jan 31, 2025
BIOA BioAge Labs, Inc. Director $41.5M Sep 25, 2024
YMAB Y-mAbs Therapeutics, Inc. Director $26.7M Jun 11, 2024
RAPP Rapport Therapeutics, Inc. Director $19.9M Jul 1, 2024
AVBP ArriVent BioPharma, Inc. Director $6.19M Jan 30, 2024
CHRS Coherus BioSciences, Inc. Director $171K Jan 7, 2022
KRTX Karuna Therapeutics, Inc. Director $0 Mar 18, 2024
BOLT Bolt Biotherapeutics, Inc. Director Jun 12, 2024
CINC CinCor Pharma, Inc. Director, 10%+ Owner Nov 28, 2022

Insider Transactions Reported by James Healy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.